http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108195988-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8809 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-88 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 |
| filingDate | 2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108195988-B |
| titleOfInvention | Schisandra chinensis medicinal material adopting HPLC fingerprint construction method and pulse activating injection preparation thereof |
| abstract | The invention discloses a schisandra chinensis medicinal material and a pulse activating injection preparation thereof by adopting a construction method of an HPLC fingerprint, and relates to the field of detection of traditional Chinese medicines and preparations. The method comprises the steps of injecting a test solution of a schisandra chinensis medicinal material or a pulse-activating injection preparation test solution into a liquid chromatograph for high performance liquid chromatography analysis to obtain an HPLC fingerprint of the schisandra chinensis medicinal material or an HPLC fingerprint of the pulse-activating injection preparation, and establishing an analysis method of the schisandra chinensis medicinal material and the pulse-activating injection preparation for evaluating the correlation of the medicinal materials and the preparation and realizing the quality control from the medicinal materials to the preparation; by establishing HPLC fingerprint spectra of the schisandra chinensis medicinal material and the pulse-activating injection preparation thereof, the relative contents of main components in the schisandra chinensis medicinal material and the preparation thereof are accurately analyzed and measured, and the product quality can be effectively and reliably predicted according to the contents, so that the quality of the medicinal material and the correlation between the medicinal material and the preparation can be comprehensively evaluated. |
| priorityDate | 2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.